Oral Updates
Esketamine trial in Netherlands (NTR6161)
Also, research from 2016 is a reminder that ketamine's effect may be independent of NMDAR. If proven it could have big implications for infusion clinics promoting IV as the best ROA.
Esketamine trial in Netherlands (NTR6161)
Also, research from 2016 is a reminder that ketamine's effect may be independent of NMDAR. If proven it could have big implications for infusion clinics promoting IV as the best ROA.